Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Silver

Showing results (61-70 of 232) with videos related to

Pageof 24
Sort By:
Annals of Internal Medicine|August 1, 1982
Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimenJ Laurence, M Coleman, S L Allen, et al.
Experientia|April 15, 1986
Position of the Y-chromosome at somatic metaphase in patients with chronic myelogenous leukemia (CML)R S Verma, S Thomas, M Coleman, et al.
Cancer Genetics and Cytogenetics|February 1, 1987
Length polymorphisms of the human Y chromosome in patients with chronic myelogenous leukemiaR S Verma, S Thomas, M Coleman, et al.
American Journal of Hematology|January 1, 1978
Guidelines for protocol studies in chronic lymphocytic leukemiaR T Silver, A Sawitsky, K Rai, et al.
Cancer Research|February 17, 2000
Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo cultureM Engelhardt, K Mackenzie, P Drullinsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
The rat RT1-A1c MHC molecule is a xenogeneic ligand recognized by the mouse activating Ly-49W and inhibitory Ly-49G receptorsKerry J Lavender, Brian J Ma, Elizabeth T Silver, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1996
Ranitidine 300 mg twice daily and 150 mg four-times daily are effective in healing erosive oesophagitisM T Silver, R H Murdock, B B Morrill, et al.
Cancer Genetics and Cytogenetics|January 1, 1985
Unusual translocations involving chromosomes 12;22 and 9;12 in a case of chronic myelogenous leukemiaS Chemitiganti, R S Verma, R T Silver, et al.
Acta Haematologica|January 1, 1995
Characterization of chromosome 11 with a complex inversion and deletion in an AML [M2] using fluorescence in situ hybridizationA F Abdelaal, R T Silver, M J Macera, et al.
Experimental Hematology|August 7, 2003
The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylateEric Feldman, Vesna Najfeld, Michael Schuster, et al.
Pageof 24

Showing results (61-70 of 232) with videos related to

Sort By:
Pageof 24
Annals of Internal Medicine|August 1, 1982
Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimenJ Laurence, M Coleman, S L Allen, et al.
Experientia|April 15, 1986
Position of the Y-chromosome at somatic metaphase in patients with chronic myelogenous leukemia (CML)R S Verma, S Thomas, M Coleman, et al.
Cancer Genetics and Cytogenetics|February 1, 1987
Length polymorphisms of the human Y chromosome in patients with chronic myelogenous leukemiaR S Verma, S Thomas, M Coleman, et al.
American Journal of Hematology|January 1, 1978
Guidelines for protocol studies in chronic lymphocytic leukemiaR T Silver, A Sawitsky, K Rai, et al.
Cancer Research|February 17, 2000
Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo cultureM Engelhardt, K Mackenzie, P Drullinsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
The rat RT1-A1c MHC molecule is a xenogeneic ligand recognized by the mouse activating Ly-49W and inhibitory Ly-49G receptorsKerry J Lavender, Brian J Ma, Elizabeth T Silver, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1996
Ranitidine 300 mg twice daily and 150 mg four-times daily are effective in healing erosive oesophagitisM T Silver, R H Murdock, B B Morrill, et al.
Cancer Genetics and Cytogenetics|January 1, 1985
Unusual translocations involving chromosomes 12;22 and 9;12 in a case of chronic myelogenous leukemiaS Chemitiganti, R S Verma, R T Silver, et al.
Acta Haematologica|January 1, 1995
Characterization of chromosome 11 with a complex inversion and deletion in an AML [M2] using fluorescence in situ hybridizationA F Abdelaal, R T Silver, M J Macera, et al.
Experimental Hematology|August 7, 2003
The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylateEric Feldman, Vesna Najfeld, Michael Schuster, et al.
Pageof 24